Development and validation of a machine learning model for predicting invasive breast cancer using 26 routine clinical examination indicators - Takeaways - MDSpire

Development and validation of a machine learning model for predicting invasive breast cancer using 26 routine clinical examination indicators

  • By

  • Lijuan Pan

  • Wenjing Deng

  • Ziwei Zhao

  • Yulong Liu

  • Xuelian Peng

  • Chunyan Yang

  • Baoru Han

  • Shan Shi

  • Jin Li

  • May 10, 2026

  • 0 min

Share

  • 1

    Invasive breast cancer (IBC) is the most common cancer among women, with approximately 2.26 million new cases diagnosed globally each year.

  • 2

    Early detection of IBC is crucial for improving patient outcomes, yet traditional diagnostic methods have significant limitations.

  • 3

    This study aims to develop machine learning models using 26 routine clinical examination indicators to predict IBC risk effectively.

  • 4

    Data from 1,175 female patients were analyzed, focusing on clinical indicators to enhance diagnostic accuracy in resource-limited settings.

  • 5

    The integration of machine learning with routine clinical data could significantly improve early recognition and treatment of IBC.

Original Source(s)

Development and validation of a machine learning model for predicting invasive breast cancer using 26 routine clinical examination indicators

  • by Lijuan Pan, Wenjing Deng, Ziwei Zhao, Yulong Liu, Xuelian Peng, Chunyan Yang, Baoru Han, Shan Shi, Jin Li

  • May 10, 2026

Related Content

Predicting preoperative axillary lymph node metastasis to guide surgical decisions in invasive breast cancer

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma